Xerostomia Therapeutics Market Analysis By Type(Artificial Saliva/Saliva Substitutes, Salivary Stimulants), By Product(Drugs, Salivary Pens), By Distribution Channel(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) & Forecast 2024-2035
- PUBLISHED ON
- 02/03/2023
- NO OF PAGES
- 267
- CATEGORY
- Healthcare & Life Sciences
Chemotherapy and radiation harm the salivary gland and results in dry mouth. Chemotherapy is the most common form of treatment to cancer patients provided by oncologists and medical practitioners. According to the Centers for Disease Control & Prevention (CDC), each year around 650,000 cancer patients take chemotherapy in an outpatient oncology clinic. The American Cancer Society evaluates that 3.5 million women live with breast cancer in the U.S., as of January 1, 2016. Among women with stage IV breast cancer, 48% accept radiation and/or chemotherapy.
Easy obtainability of cost-effective medicines is among the key drivers of the market. Products comprise saliva substitute gels, mouthwashes & oral rinses, sugar-free chewing gums, lozenges, toothpastes & oral-adhering discs, patches, and melts. The price of these products range from USD 10 to 90 and the reimbursement strategies of these products are favourable. For example, Ontario Ministry of Health and Long-Term Care provides funds to patients with radiation-induced xerostomia enduring treatment with drug, Salagen, in the Exceptional Access Program (EAP).
Upsurge in use of prescription medicines is projected to definitely disturb the market growth. As per the National Institute of Dental and Craniofacial Research, over 400 medicines may cause xerostomia. Prescription medicines such as antihypertensives, antidepressants, sedatives, antiparkinson, antiemetics, and antipsychotics distress the salivary gland and results in xerostomia. Growing prevalence of diseases such as hypertension, Parkinson’s disease, diabetes, and HIV lead to use of prescription drugs, thus instigating the state of dry mouth.
The COVID-19 pandemic has modelled new problems in all aspects of an individual’s life, comprising oral health. Dry mouth has developed as one of the most common difficulties that patients from all walks of life are dealing with. COVID-19 has remained related to dry mouth as an indication. As per the article titled "Xerostomia in patients with COVID-19: a case series" published in April 2021, dry mouth seemed in 60% of circumstances 3–4 days before as a prodromal symptom and in others, simultaneously or 1–2 days after the beginning of other symptoms. In most of the cases, dry mouth improved over time after beginning treatment. The study also stated that in COVID-19 patients, xerostomia may grow before the beginning of the common symptoms. Such studies establish the occurrence of the disorder in COVID-19 patients and henceforth suggest that the request for therapeutics for dry mouth disease is estimated to grow in the near future. Consequently, COVID-19 is anticipated to have a definite effect on the growth of the market.
Type Insights
Based on the type, artificial saliva/saliva substitutes segment is projected to rule the market over the forecasted period.
The reduction of saliva in the mouth can cause the tooth decay, mouth infections, an altered sense of taste or smell, trouble in swallowing, pain, and many other difficulties. Artificial saliva is a liquid or aerosol product that is sprayed into the mouth. They are aimed to moisten and relieve the pain and uneasiness of chronic dry mouth, particularly with regular use. Many artificial saliva sprays and gels claim to work for up to two hours, and many operators need extra applications to maintain moisture in the mouth, which can significantly restrict with sleep and daily activity. Numerous saliva sprays and gels also have a reputation for strong and unpleasant flavours, though a recent increase in the use of naturally sweet xylitol has led to the obtainability of better substitutes.
Factors such as the rising burden of dry mouth disease and growing research studies are driving the growth of the market segment. For example, the article named "Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed Versus Placebo" issued in July 2020, determined that the use of Aldiamed spray was presented to be more active than a placebo in the management of xerostomia in type 1 and type 2 diabetes. Such studies prove that saliva substitutes are operative for the treatment of xerostomia. The stated source also described that the dry mouth symptom is one of the most common oral complaints in patients with diabetes mellitus. Moreover, the prevalence of xerostomia and hyposalivation has been described to grow with age. The study also intends that there may be growing demand for saliva substitutes in the future years as the load of diabetes mellitus and the geriatric population is anticipated to show fast growth in the near future.
Distribution Channel Insights
On the basis of distribution channel, the xerostomia therapeutics market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The hospital pharmacies category is to observe higher adoption of xerostomia therapeutics during the forecasted period. This is mostly owing to the accessibility of experienced healthcare professionals & the safety & efficiency throughout the treatment procedures also increasing hospital administration of patients globally are the major aspects for the growth of the segment.
Region Insights
North America dominated the regional segment with the largest share of revenue followed by Europe. Key factors donating toward governance are growing prevalence of xerostomia and other dry mouth related diseases such as rheumatoid arthritis, Sjogren’s syndrome, and HIV combined with rise in dry mouth awareness initiatives. For example, Sjogren Syndrome Foundation of the U.S. is accountable for conducting awareness and assisting patients with xerostomia in the U.S. and Canada.
However, Asia Pacific is estimated to grow with a beneficial CAGR over the forecast period owing to rising healthcare expenditure, rise in initiatives for raising awareness, and growing prevalence of diseases such as HIV, cancer, diabetes, & Parkinson’s disease that cause dry mouth situations. Cancer rates are increasing drastically in the Asia-Pacific region. For example, as per GLOBOCAN 2020, there were 9,386,454 new cases of cancer in Asia, and it is expected to reach 14,229,878 by 2040. Developing economies, such as China and India, have implemented both health and industrial policies to inspire the domestic production of cancer drugs, which is aiming to inferior therapy costs. Lower therapy costs along with growing awareness about cancer, are intending to higher adoption of chemotherapy and radiotherapy. The growing burden of cancer leads to better adoption of radiotherapy and chemotherapy, along with the dry mouth conditions associated with the treatments. Thus, this generates the need for therapeutics for considering xerostomia, which eventually boosts the market growth in the region.
Key Companies Insights
The market for Xerostomia therapeutics is moderately competitive. With the rising applications of Xerostomia therapeutics, new players are considering to enter the market. The companies are also involved in events like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the Xerostomia therapeutics market, ultimately boosting the market growth.
• GlaxoSmithKline PLC
• Parnell Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• 3M company
• Quest Products Inc.
• Fresenius SE & Co. KGaA
• Hikma Pharmaceuticals PLC
• Lupin Limited
• Sun Pharmaceutical Industries Ltd
• Sanofi (Chattem, Inc.)
• Synedgen Inc. (Prisyna)
• ADVANZ PHARMA Corp. Limited
• Saliwell Ltd
• Pharmascience Inc (Pendopharm)
• Other players
Some of the Recent Developments:
• In September 2021, ICPA Health Products (ICPA) announced Wet Mouth, a saliva substitute for treating people suffering from xerostomia (dry mouth).
• In February 2021, Virginia Head and Neck Therapeutics, Inc., launched Voutia, which provides continuous relief from xerostomia (chronic dry mouth). The patented, FDA-cleared device offers an exclusively new method for millions of people suffering from this painful and often debilitating condition.
Segments
By Type
• Artificial Saliva/Saliva Substitutes
• Salivary Stimulants
By Product
• Drugs
• Salivary Pens
• Other Product Types
By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI